CAS 603101-22-0

GNF-1331

CAS: 603101-22-0

GNF-1331 is a drug candidate that binds to the extracellular domain of the CD20 receptor and inhibits its function. This drug has been shown to inhibit tumor growth in xenograft models, as well as inhibit cancer cell proliferation and induce apoptosis. GNF-1331 has also been shown to have an effect on cellular metabolism by inhibiting fatty acid synthesis, which may be due to its ability to selectively bind with acyl chains.

Fórmula: C₂₀H₂₀N₆O₂S₂

Pureza: Min. 95%

Peso molecular: 440.5 g/mol

Ref: 3D-DZA10122

GNF-1331

CAS: 603101-22-0

GNF-1331: potent, selective oral porcupine inhibitor; IC50=12 nM; targets aberrant Wnt signaling in cancers.

Fórmula: C₂₀H₂₀N₆O₂S₂

Forma y color: Solid

Peso molecular: 440.54

Ref: TM-T31983